Bids Are invited for Inj Nivolumab 240Mg , Inj Bevacizumab 800 Mg , Tab Darolutamide 600Mg , Inj Cycloposphamide 500Mg Plus 250Ml Ns Plus Darzalex Faxpro 1800Mg - Inj Cycloposphamide 500Mg + 250Ml Ns+Darzalex Faxpro 1800Mg , Inj Avelumab 800 Mg
Tender Overview
Project Description
Bids Are invited for Inj Nivolumab 240Mg , Inj Bevacizumab 800 Mg , Tab Darolutamide 600Mg , Inj Cycloposphamide 500Mg Plus 250Ml Ns Plus Darzalex Faxpro 1800Mg - Inj Cycloposphamide 500Mg + 250Ml Ns+Darzalex Faxpro 1800Mg , Inj Avelumab 800 Mg
BOQ
| Sl. No. | Item Title | Item Description |
| 1 | Inj Nivolumab 240mg | Inj Nivolumab 240mg |
| 2 | Inj Bevacizumab 800 mg | Inj Bevacizumab 800 mg |
| 3 | Tab Darolutamide 600mg | Tab Darolutamide 600mg |
| 4 | inj Cycloposphamide 500mg plus 250ml NS plus Darzalex Faxpro 1800mg | inj Cycloposphamide 500mg + 250ml NS+Darzalex Faxpro 1800mg |
| 5 | Inj Avelumab 800 Mg | Inj Avelumab 800 Mg |
AI Tender Summary
Tender Timeline
Tender Published
Tender notice published.
CompletedBid Submission Deadline
Online submission via eProcurement portal.
Upcoming · 5 daysBid Opening Date
Technical bids will be opened and evaluated.
Upcoming · 5 daysTender Documents
Download All (ZIP) ↓We takes all possible care for accurate & authentic tender information. However users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender